Clinical Trial Update: A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine ± erlotinib with DN-101 versus gemcitabine ± erlotinib with placebo in advanced pancreatic cancer; the study is currently s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• DN-101
• Gemzar (gemcitabine)
• Tarceva (erlotinib)

Snippet

Sponsor: Novacea | Conditions: Pancreatic Cancer | Phase 2 | Status: SUSPENDED